Treatment-Resistant Depression News

Latest Articles

• New Zealand Researchers Target Global Market with Breakthrough Ketamine Tablet

  Published: Apr 14, 2026

  Section: Medical News

  A team of New Zealand scientists is moving closer to a major medical milestone, developing a slow-release ketamine tablet aimed at treating the 300,000 New Zealanders—and millions...

• Groundbreaking Brain Medicine Study Reveals Autonomic Nervous System Imbalances as Primary Driver of Treatment-Resistant Depression

  Published: Mar 31, 2026

  Section: Health

  A six-year clinical study involving over 8,000 patients has found that a significant majority of individuals diagnosed with treatment-resistant depression actually suffer from meas...

• Japanese Researchers Identify NOX-1 Enzyme as Key to Extending Ketamine’s Rapid Antidepressant Effects

  Published: Mar 30, 2026

  Section: Research

  A research team at Yokohama City University has discovered that suppressing the enzyme NOX-1 can significantly prolong the therapeutic benefits of ketamine. By inhibiting this enzy...

• Yokohama City University Researchers Identify NOX-1 Enzyme as Key to Extending Ketamine’s Antidepressant Effects

  Published: Mar 30, 2026

  Section: Environment

  A research team in Japan has uncovered a molecular mechanism that explains why ketamine’s rapid relief for treatment-resistant depression is often short-lived. By inhibiting the NO...

• UCLA Study: Accelerated 5-Day Brain Stimulation Matches Efficacy of 6-Week Depression Treatment

  Published: Feb 25, 2026

  Section: Science & Tech

  Researchers at UCLA Health have demonstrated that compressing Transcranial Magnetic Stimulation (TMS) into a high-intensity, five-day "5x5" protocol can provide symptom relief comp...